Severe Adenovirus Pneumonia Associated With Hemophagocytic Lymphohistiocytosis With Coronary Involvement

[1] Bradley JS(2011)The management of Community-acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America Clin Infect Dis 53 e25-76

[2] Byington CL(2004)Respiratory adenoviral infections in children: a study of hospitalized cases in southern Taiwan in 2001–2002 J Trop Pediatr 50 279-84

[3] Shah SS(2013)A child with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis complicated by coronary artery lesion mimicking kawasaki disease J Pediatr Hematol Oncol 35 317-9

[4] Chen HL(2020)Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis Arth Rheumatol 72 326-34

[5] Chiou SS(2014)Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children Pediatr Critic Care Med 15 401-8

[6] Hsiao HP(2022)Anakinra for the treatment of hemophagocytic lymphohistiocytosis: 21 cases J Clin Med 11 5799-undefined

[7] Kato S(undefined)undefined undefined undefined undefined-undefined

[8] Yoshimura K(undefined)undefined undefined undefined undefined-undefined

[9] Tanabe Y(undefined)undefined undefined undefined undefined-undefined

[10] Eloseily EM(undefined)undefined undefined undefined undefined-undefined

[1] Bradley JS(2011)The management of Community-acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America Clin Infect Dis 53 e25-76

[2] Byington CL(2004)Respiratory adenoviral infections in children: a study of hospitalized cases in southern Taiwan in 2001–2002 J Trop Pediatr 50 279-84

[3] Shah SS(2013)A child with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis complicated by coronary artery lesion mimicking kawasaki disease J Pediatr Hematol Oncol 35 317-9

[4] Chen HL(2020)Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis Arth Rheumatol 72 326-34

[5] Chiou SS(2014)Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children Pediatr Critic Care Med 15 401-8

[6] Hsiao HP(2022)Anakinra for the treatment of hemophagocytic lymphohistiocytosis: 21 cases J Clin Med 11 5799-undefined

[7] Kato S(undefined)undefined undefined undefined undefined-undefined

[8] Yoshimura K(undefined)undefined undefined undefined undefined-undefined

[9] Tanabe Y(undefined)undefined undefined undefined undefined-undefined

[10] Eloseily EM(undefined)undefined undefined undefined undefined-undefined